Author:
Zhang Yong-Fa,Zhou Jie,Wei Wei,Zou Ru-Hai,Chen Min-Shan,Lau Wan Yee,Shi Ming,Guo Rong-Ping
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, Raoul JL, Sangro B (2012) Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis 32 (4): 348–359.
2. Bruix J, Sala M, Llovet JM (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127 (5 Suppl 1): S179–S188.
3. Bruix J, Sherman M (2005) Practice Guidelines Committee American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42 (5): 1208–1236.
4. Chow PK (2012) Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria? J Gastroenterol Hepatol 27 (3): 452–457.
5. Colombo M, Sangiovanni A (2015) Treatment of hepatocellular carcinoma: beyond international guidelines. Liv Int 35 (Suppl 1): 129–138.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献